SE0001075D0 - Use of at least one nicotine-based substance and / or substance derived from this substance for the manufacture of a medicament and method for the treatment of obstructive pulmonary diseases - Google Patents

Use of at least one nicotine-based substance and / or substance derived from this substance for the manufacture of a medicament and method for the treatment of obstructive pulmonary diseases

Info

Publication number
SE0001075D0
SE0001075D0 SE0001075A SE0001075A SE0001075D0 SE 0001075 D0 SE0001075 D0 SE 0001075D0 SE 0001075 A SE0001075 A SE 0001075A SE 0001075 A SE0001075 A SE 0001075A SE 0001075 D0 SE0001075 D0 SE 0001075D0
Authority
SE
Sweden
Prior art keywords
substance
nicotine
medicament
manufacture
treatment
Prior art date
Application number
SE0001075A
Other languages
Swedish (sv)
Inventor
Laszlo Bense
Original Assignee
Laszlo Bense
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9903085A external-priority patent/SE516807C2/en
Application filed by Laszlo Bense filed Critical Laszlo Bense
Priority to SE0001075A priority Critical patent/SE0001075D0/en
Publication of SE0001075D0 publication Critical patent/SE0001075D0/en
Priority to CA002382567A priority patent/CA2382567A1/en
Priority to AU70477/00A priority patent/AU7047700A/en
Priority to EP00959096A priority patent/EP1207883A1/en
Priority to PCT/SE2000/001683 priority patent/WO2001015697A1/en

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention refers to a use of at least one substance based on nicotine and/or a substance produced from said one substance for the manufacture of a medicament to be supplied to an individual of a human being or an animal for the purpose of counteracting, in a prophylactic or therapeutic manner, obstructive lung diseases, in particular pulmonary emphysema. The medicament is intended to be supplied via the blood path and to be administered via the gastrointestinal tract, transdermally, intravascularly, intranasally or intravaginally. The invention also refers to a method for prophylactic or therapeutic treatment of obstructive lung diseases of an individual of a human being or an animal, wherein said individual is supplied with a nicotine-based substance.
SE0001075A 1999-09-01 2000-03-27 Use of at least one nicotine-based substance and / or substance derived from this substance for the manufacture of a medicament and method for the treatment of obstructive pulmonary diseases SE0001075D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE0001075A SE0001075D0 (en) 1999-09-01 2000-03-27 Use of at least one nicotine-based substance and / or substance derived from this substance for the manufacture of a medicament and method for the treatment of obstructive pulmonary diseases
CA002382567A CA2382567A1 (en) 1999-09-01 2000-09-01 Use of at least one substance based on nicotine and/or a substance produced from said one substance for the manufacture of a medicament, and a method for treatment of obstructive lung disease
AU70477/00A AU7047700A (en) 1999-09-01 2000-09-01 Use of at least one substance based on nicotine and/or a substance produced fromsaid one substance for the manufacture of a medicament, and a method for treatm ent of obstructive lung diseases
EP00959096A EP1207883A1 (en) 1999-09-01 2000-09-01 Use of at least one substance based on nicotine and/or a substance produced from said one substance for the manufacture of a medicament, and a method for treatment of obstructive lung diseases
PCT/SE2000/001683 WO2001015697A1 (en) 1999-09-01 2000-09-01 Use of at least one substance based on nicotine and/or a substance produced from said one substance for the manufacture of a medicament, and a method for treatment of obstructive lung diseases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903085A SE516807C2 (en) 1999-09-01 1999-09-01 Use of nicotine based substances to treat obstructive lung diseases
SE0001075A SE0001075D0 (en) 1999-09-01 2000-03-27 Use of at least one nicotine-based substance and / or substance derived from this substance for the manufacture of a medicament and method for the treatment of obstructive pulmonary diseases

Publications (1)

Publication Number Publication Date
SE0001075D0 true SE0001075D0 (en) 2000-03-27

Family

ID=26655041

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0001075A SE0001075D0 (en) 1999-09-01 2000-03-27 Use of at least one nicotine-based substance and / or substance derived from this substance for the manufacture of a medicament and method for the treatment of obstructive pulmonary diseases

Country Status (5)

Country Link
EP (1) EP1207883A1 (en)
AU (1) AU7047700A (en)
CA (1) CA2382567A1 (en)
SE (1) SE0001075D0 (en)
WO (1) WO2001015697A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2341952A1 (en) * 2001-03-23 2002-09-23 Universite Laval Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases
US8557804B2 (en) 2002-03-25 2013-10-15 Universite Laval Nicotinic receptor agonists for the treatment of inflammatory diseases
US8039459B2 (en) 2004-07-15 2011-10-18 Universite Laval Nicotinic receptor agonists for the treatment of inflammatory diseases
WO2006005195A1 (en) * 2004-07-15 2006-01-19 UNIVERSITé LAVAL Nicotinic receptor agonists for the treatment of inflammatory diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998034615A1 (en) * 1997-02-07 1998-08-13 Synapse Pharmaceuticals International, Inc. Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime

Also Published As

Publication number Publication date
CA2382567A1 (en) 2001-03-08
WO2001015697A1 (en) 2001-03-08
AU7047700A (en) 2001-03-26
WO2001015697A8 (en) 2002-01-03
EP1207883A1 (en) 2002-05-29

Similar Documents

Publication Publication Date Title
CY1118517T1 (en) Pulmonary administration for levodopa
DE69526425D1 (en) USE OF MOMETASONE-FUROAT TO TREAT AIR AND LUNG DISEASES
BR0311451A (en) Liquid nicotine buffered composition for pulmonary administration
DK1406688T3 (en) Respiratory device for keeping a human body's natural airways free, as well as application methods for preventing snoring sounds
CY1107981T1 (en) PROVISION FOR CONTROLLED INSPECTION OF THERAPEUTIC
DE60002885D1 (en) AQUEOUS FORMULATION FOR NASAL ADMINISTRATION
ATE144142T1 (en) USE OF THIAZOLIDINE-4-CARBOXYLATE DERIVATIVES FOR THE TREATMENT OF LUNG DISEASES
SE0000601D0 (en) Methods to treat and diagnose respiratory disorders in sleep and agents to perform the procedure
WO2003079993A3 (en) hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION
EA200701077A1 (en) APPLICATION OF LIPID CONJUGATES IN THE TREATMENT OF DISEASES
SE0001075D0 (en) Use of at least one nicotine-based substance and / or substance derived from this substance for the manufacture of a medicament and method for the treatment of obstructive pulmonary diseases
EE04330B1 (en) Transmucosal formulations of levosimendan and their use in the manufacture of a medicament
ATE271852T1 (en) IMPROVED INHALATION PREPARATIONS
BR9914945A (en) Process for providing medical / medicinal therapy
CN202844292U (en) Trachea incision atomization cover
MXPA04002401A (en) Novel medicaments for inhalation.
PL335758A1 (en) Application bird's antibodies
CN210933232U (en) Nasal plug fixing device for oxygen inhalation in cardiovascular department
SE9903085L (en) Use of at least one nicotine-based substance and / or a substance prepared from this substance for the manufacture of a medicament
EA199900568A1 (en) METHOD OF IMPROVING RESPIRATION IN DREAM
SU971336A1 (en) Antiinflammatory agent for treating tuberculosis and non-specific chronic inflammatory diseases of lungs
JPH027570Y2 (en)
Oswald Expectoration of Shell Fragment after 29 years
Hargrove Impaction of Gentian Pill in Larynx of Child aged 2
Hicks et al. " How I do it"--head and neck and plastic surgery. A targeted problem and its solution. A saliva shunting technique for low anterior neck pharyngeal fistulas after laryngectomy--an emergency procedure